Microarray Solutions for Prenatal Genetic Research

Make confident decisions with trusted microarray solutions, from samples to insights

With advances in genetic research technologies, various types of causative genetic aberrations associated with disorders can be studied prenatally with chromosomal microarray analysis (CMA). Because of the increased density and exceptional resolution compared to traditional karyotypes, CMA is rapidly becoming the established method for prenatal genetic research. In fact, American College of Obstetricians and Gynecologists (ACOG) proposes that CMA be used as the primary prenatal genetic analysis method of choice. This is based on the major advantage of CMA over standard karyotyping in terms of discovery yield. 

 

Thermo Fisher Scientific provides high-resolution microarray research solutions that cytogeneticists trust to improve accuracy and efficiency. With reproducible results, automated data interpretation and hands-on support, Thermo Fisher Scientific is your trusted partner from start to finish. 

Customer and solutions overview

Raise your productivity to a whole new level

Hip Hip array! The new CytoScan Cytogenetics Suite with a two-day turnaround time, improved coverage, and automated interpretation and reporting capabilities is now available.

Enhance efficiency and productivity in cytogenetic analysis with the CytoScan HD Accel Suite

The informative white paper examines the obstacles in efficiency and productivity that laboratories face when striving to deliver reliable and reproducible results. The all new Applied Biosystems™ CytoScan™  HD Accel Suite is designed to help overcome these obstacles.

Challenging microarray cases and approaches for analysis of unusual findings

Dr. Stuart Schwartz of Labcorp explains how hybrid-SNP arrays advance prenatal cytogenetics research.

Overcoming today's lab challenges with CytoScan HD Accel

Dr. Debbie Black discusses the substantial advancements the new CytoScan HD Accel Array brings such as, two-day turnaround time, improved probe coverage, a new reference model that allows users to obtain more pertinent insights in less time compared to the currently dominant microarray in the market, boosting lab productivity by up to 100%.

Powerfully efficient cytogenetics analysis

Move science forward with reproducible microarray solutions. Learn more about our whole-genome Hybrid-SNP arrays from this interactive brochure.

Constitutional genetic testing: chromosomal microarrays or exome sequencing?

Technological advances have led to the emergence of high-resolution, genome-wide methods for chromosomal disorder analysis, namely chromosomal microarray analysis (CMA), exome sequencing (ES), and genome sequencing (GS). Read our latest whitepaper to find out which of these technologies is best for optimal outcomes.

CytoScan arrays

 

 

 

Chromosome Analysis Suite Software

 

 

 

For Research Use Only. Not for use in diagnostic procedures.